-
Article
Prophylaxis against intraocular pressure spikes following uncomplicated phacoemulsification: a systematic-review and meta-analysis
To investigate the effect of perioperative intraocular pressure (IOP) lowering medications on controlling postoperative IOP following uncomplicated phacoemulsification.
-
Article
Open AccessMinimally invasive micro sclerostomy (MIMS) procedure in the treatment of open-angle glaucoma
To evaluate the safety and efficacy of the Minimally Invasive Micro Sclerotomy (MIMS) procedure in the management of uncontrolled open-angle glaucoma.
-
Article
Open AccessNew Devices in Glaucoma
Glaucoma remains a leading cause of blindness globally. Minimally invasive treatment techniques are rapidly expanding the availability of therapeutic options for glaucoma. These include devices aimed at enhanc...
-
Article
Open AccessSubconjunctival filtration in evolution: current evidence on MicroShunt implantation for treating patients with glaucoma
Although traditional surgical procedures for glaucoma (such as trabeculectomy and tube-shunt implantation) can significantly reduce intraocular pressure (IOP), they are associated with numerous complications, ...
-
Article
Associations in corticocapsular adhesions
To determine the patient-related factors that contribute to intraoperative corticocapsular adhesions (CCA) during phacoemulsification cataract extraction (PCE).
-
Reference Work Entry In depth
Phacoemulsification in Complex Cases
Cataract surgery is the most commonly performed ophthalmic surgical operation. Most ophthalmologists learn and use a standardized surgical approach, and truth be told, for the majority of cataract cases, this ...
-
Reference Work Entry In depth
Minimally Invasive Glaucoma Surgery (MIGS)
With an ever-growing field of glaucoma surgery, countless options are now available to surgeons to help better control the single most important risk factor to glaucoma progression: intraocular pressure (IOP)....
-
Chapter
PRESERFLO MicroShunt
The PRESERFLO® MicroShunt (Santen Pharmaceutical Co. Ltd., Osaka, Japan), formerly called the InnFocus MicroShunt®, is a trans-scleral device that shunts aqueous humour from the anterior chamber to a filtering bl...
-
Living Reference Work Entry In depth
Minimally Invasive Glaucoma Surgery (MIGS)
With an ever-growing field of glaucoma surgery, countless options are now available to surgeons to help better control the single most important risk factor to glaucoma progression: intraocular pressure (IOP)....
-
Chapter
Controversies in the Use of MIGS
Minimally invasive glaucoma surgery (MIGS) has fulfilled an unmet need in the management of glaucoma. This chapter highlights some controversial issues regarding the use of MIGS in clinical practice, including...
-
Article
Open AccessCurrent review of Excimer laser Trabeculostomy
Excimer laser trabeculostomy (ELT) is a microinvasive glaucoma surgery (MIGS) that creates multiple laser channels through the trabecular meshwork using a cold laser system, which minimizes tissue fibrosis and...
-
Article
Open AccessOpen-Angle Glaucoma: Burden of Illness, Current Therapies, and the Management of Nocturnal IOP Variation
Glaucoma is a chronic, debilitating disease and a leading cause of global blindness. Despite treatment efforts, 10% of patients demonstrate loss of vision. In the US, > 80% of glaucoma cases are classified as ...
-
Article
Open AccessHydrus microstent implantation for surgical management of glaucoma: a review of design, efficacy and safety
With the advent of microinvasive glaucoma surgery (MIGS), the spectrum of modalities available to manage patients with this chronic and heterogeneous condition has broadened. Despite its novelty however, there...
-
Article
Open AccessShort-Term Safety Evaluation of a Multi-Pressure Dial: A Prospective, Open-label, Non-randomized Study
Prospective, open-label, non-randomized, single site study to assess the safety and tolerability of a multi-pressure dial.
-
Article
Open AccessProspective Evaluation of Two iStent® Trabecular Stents, One iStent Supra® Suprachoroidal Stent, and Postoperative Prostaglandin in Refractory Glaucoma: 4-year Outcomes
This study evaluates long-term outcomes of two trabecular micro-bypass stents, one suprachoroidal stent, and postoperative prostaglandin in eyes with refractory open angle glaucoma (OAG).
-
Chapter
Glaucoma Devices
Glaucoma is a progressive optic neuropathy of unknown origin. It is characterized by an accentuated excavation of the optic nerve head, peripheral loss of the visual field and thinning of the nerve fiber layer...
-
Article
Open AccessErratum to: Newly Diagnosed Primary Open-Angle Glaucoma Randomized to 2 Trabecular Bypass Stents or Prostaglandin: Outcomes Through 36 Months
-
Article
Open AccessNewly Diagnosed Primary Open-Angle Glaucoma Randomized to 2 Trabecular Bypass Stents or Prostaglandin: Outcomes Through 36 Months
To examine outcomes through 36 months in phakic eyes with newly diagnosed primary open-angle glaucoma (POAG) naïve to therapy randomized to treatment with two trabecular micro-bypass stents or topical prostagl...
-
Chapter
Intraocular Lens Complications and Management
In 5 B.C., Sanskrit manuscripts first described couching, the procedure by which a needle is placed into the eye and an opa lescent lens pushe d into the vit reous cavity in order to clear the visual axis. In ...
-
Chapter
Approach to Cataract Extraction Combined with New Glaucoma Devices
Both the incidence of glaucoma and cataract increases in the aging population, and the surgical treatment of glaucoma increases the rate of progression of cataractous lens opacity. So, it follows that the simu...
